Release Date: 30/04/12 09:12 Summary: Appendix 5B March 2012 Price Sensitive: Yes Download Document 294.12KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%